当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 资产负债表

海尔生物

(688139)

  

流通市值:89.69亿  总市值:89.69亿
流通股本:3.18亿   总股本:3.18亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金1,269,279,665.661,288,305,956.44953,053,525.121,279,807,164.26
应收票据及应收账款198,490,057.39267,754,767.36255,220,943.66211,218,341.13
其中:应收票据10,812,393.3811,795,590.624,634,142.553,282,725
应收账款187,677,664.01255,959,176.74250,586,801.11207,935,616.13
应收款项融资9,858,43212,595,352.9615,136,656.6119,856,091.96
预付款项18,986,138.4519,497,246.1921,160,815.2918,789,306.02
其他应收款合计7,470,708.638,902,957.1610,499,591.323,855,197.97
应收股利--100,000-
存货248,019,202.28198,252,598.05208,612,257.75217,833,366.81
一年内到期的非流动资产108,105,833---
其他流动资产24,677,943.1115,695,557.3712,349,564.685,212,826.57
流动资产平衡项目0000
流动资产合计2,536,028,043.522,636,531,294.082,893,908,129.693,224,795,967.12
非流动资产:
长期股权投资130,300,034126,028,666.12124,192,717.81124,084,795.77
其他权益工具投资56,878,493.0672,542,333.2772,542,333.27108,554,738.94
其他非流动金融资产9,000,000---
投资性房地产9,626,308.479,818,469.7210,015,391.9410,213,661.2
固定资产779,564,272.26761,969,373.61513,042,152.52396,900,155.89
在建工程70,333,719.4281,249,355.05317,697,977.36417,434,026.54
使用权资产12,320,322.6312,860,801.8214,284,190.8615,434,603.93
无形资产367,727,127.7370,755,878.8378,003,935.31307,055,488.87
商誉642,678,363.46642,365,428.83642,895,735.85451,507,455.71
长期待摊费用5,693,496.496,064,681.936,429,534.046,079,207.75
递延所得税资产51,673,543.2945,421,554.5834,972,603.6529,135,787.82
其他非流动资产853,858,844.37726,759,134.21481,437,342.71435,577,697.22
非流动资产平衡项目0000
非流动资产合计2,989,654,525.152,855,835,677.942,595,513,915.322,301,977,619.64
资产平衡项目0000
资产总计5,525,682,568.675,492,366,972.025,489,422,045.015,526,773,586.76
流动负债:
短期借款6,006,328.776,004,277.789,006,750.3810,011,720.43
应付票据及应付账款390,975,920.28425,805,909.71444,295,941.87495,710,315.1
其中:应付票据105,303,137.63158,804,056.3152,944,677.28150,873,541.44
应付账款285,672,782.65267,001,853.41291,351,264.59344,836,773.66
合同负债111,810,614.1962,085,892.1269,907,598.04161,480,976.18
应付职工薪酬80,560,952.7383,025,885.0674,799,811.1360,831,834.44
应交税费52,480,831.554,510,617.255,586,910.3647,240,408.07
其他应付款合计276,316,717.98266,156,680.73318,277,570.05281,899,713.16
一年内到期的非流动负债14,796,701.6212,509,725.8913,947,250.2213,991,385.77
其他流动负债8,715,425.736,379,224.867,355,988.2915,174,164.55
流动负债平衡项目0000
流动负债合计941,663,492.8916,478,213.35993,177,820.341,086,340,517.7
非流动负债:
租赁负债8,689,1788,859,840.449,136,074.4910,744,531.16
长期应付款52,671,673.1652,056,584.5151,441,495.8650,826,407.21
预计负债7,080,650.726,833,6856,833,6858,198,375.54
递延收益28,619,706.9330,759,997.2931,568,777.6732,377,558.2
递延所得税负债46,994,868.3449,329,311.5950,687,166.1841,578,632.26
其他非流动负债-10,706,30010,706,30010,706,300
非流动负债平衡项目0000
非流动负债合计144,056,077.15158,545,718.83160,373,499.2154,431,804.37
负债平衡项目0000
负债合计1,085,719,569.951,075,023,932.181,153,551,319.541,240,772,322.07
所有者权益(或股东权益):
实收资本(或股本)317,952,508317,952,508317,952,508317,952,508
资本公积1,987,033,409.261,999,702,724.531,998,428,923.191,996,210,670.7
减:库存股99,742,186.0899,742,186.0899,742,186.0899,742,186.08
其他综合收益10,372,509.7323,378,187.6123,915,573.1153,992,057.28
盈余公积158,976,254158,976,254158,976,254158,976,254
未分配利润1,856,118,434.591,807,246,071.821,728,507,632.271,730,001,637.38
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,230,710,929.54,207,513,559.884,128,038,704.494,157,390,941.28
少数股东权益209,252,069.22209,829,479.96207,832,020.98128,610,323.41
股东权益平衡项目0000
股东权益合计4,439,962,998.724,417,343,039.844,335,870,725.474,286,001,264.69
负债和股东权益合计5,525,682,568.675,492,366,972.025,489,422,045.015,526,773,586.76
公告日期2024-03-282023-10-272023-08-302023-04-26
审计意见(境内)标准无保留意见
TOP↑